View Post

ASTRO issues first clinical guideline on radiation therapy for cervical cancer

In In The News by Barbara Jacoby

Recommendations address external beam radiation, chemoradiation and brachytherapy for postoperative and definitive management of nonmetastatic disease A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline—ASTRO’s first for cervical cancer—outlines indications and best practices for external beam radiation therapy and brachytherapy in the postoperative …

View Post

Ask the Expert: 8 Things to Consider About Treatment for MBC

In In The News by Barbara Jacoby

From: healthline.com 1. What treatments are available for postmenopasal women with MBC The metastatic breast cancer (MBC) treatment plan your doctor will recommend depends on whether the tumors have receptors for estrogen or progesterone or elevated levels of human epidermal growth factor receptor 2 (HER2). These are known as a tumor’s biologic subtype. There are various targeted therapies for each …

View Post

What You Need to Know About the FDA’s Approval of Tukysa for HER2-Positive Breast Cancer

In In The News by Barbara Jacoby

By: Beth Fand Incollingo and Kristi Rosa From: curetoday.com By approving Tukysa (tucatinib) for use with the targeted drug Herceptin (trastuzumab) and the chemotherapy Xeloda (capecitabine), the Food and Drug Administration has provided a meaningful option to heavily pretreated patients with inoperable, locally advanced or metastatic HER2-positive breast cancer, including those with brain metastases, according to Dr. Rashmi Murthy. This …

View Post

Important Patient-Provider Conversations in the Metastatic Breast Cancer Space

In In The News by Barbara Jacoby

By: BRIELLE BENYON From: oncnursingnews.com The landscape of metastatic hormone receptor (HR)-positive breast cancer continues to evolve, highlighting the necessity of genetic and genomic testing, explained Elisa Krill-Jackson, MD. In a recent interview with Oncology Nursing News, Krill-Jackson, a breast medical oncologist at the University of Miami Sylvester Comprehensive Cancer Center, discussed these changes, as well as the important conversations …

View Post

Here’s What Patients With Breast Cancer Need to Know About CDK 4/6 Inhibitors

In In The News by Barbara Jacoby

By: Conor Killmurray From: curetoday.com As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug. CDK 4/6 inhibitors have changed the way treatment is thought about and given for patients with breast cancer, but the cost and side effects associated …

View Post

App Detects Harsh Side Effect of Breast Cancer Treatment

In In The News by Barbara Jacoby

From: gatech.edu Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment. The lymphedema monitoring technology originated through research at the Georgia Institute of Technology and was …

View Post

Survey finds 1 in 3 patients needed more information on cancer treatment side effects

In In The News by Barbara Jacoby

From: prnewswire.com Nationwide survey identifies gaps in patient counseling and informed consent processes for radiation therapy, surgery and chemotherapy One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice. The national survey of more than 400 U.S. …

View Post

Cognitive-Behavioral Therapy Reduces Endocrine Treatment Side Effects in Breast Cancer Patients

In Clinical Studies News by Barbara Jacoby

By: Lidia Schapira, MD From: medscape.com Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial Study Summary Adjuvant endocrine therapy for breast cancer, through treatment-induced profound estrogen deprivation, leads to hot flashes (HF) and night sweats (NS). These symptoms affect women’s daily functioning and health-related quality of life and, …

View Post

Chemotherapy For Breast Cancer: Overcoming The Side Effects

In In The News by Barbara Jacoby

By: Dr. Omiete Charles-Davies Chemotherapy is the use of drugs or chemicals to treat an illness or disease, which in this case is, breast cancer. It involves giving patients anti-cancer drugs called cytotoxic drugs – which literally means cell (cyto) killing (toxic). Chemotherapy is used to also control the spread of breast cancer, reduce symptoms or prevent a recurrence. Chemotherapy …

Living With Cancer: The New Medicine

In In The News by Barbara Jacoby

By: Susan Gubar From: nytimes.com In his 2010 book “The Emperor of All Maladies,” Dr. Siddhartha Mukherjee lamented the gap between “the new science” going on in research laboratories and “the old medicine” most cancer patients receive. Yet for almost two years, I have benefited from the new medicine derived from the new science, much to my surprise. Every month, …